Olfactory-Trigeminal Interactions in Patients with Parkinson's Disease.

Parkinson’s disease chemosensory interactions olfactory dysfunction trigeminal system

Journal

Chemical senses
ISSN: 1464-3553
Titre abrégé: Chem Senses
Pays: England
ID NLM: 8217190

Informations de publication

Date de publication:
01 01 2021
Historique:
pubmed: 10 4 2021
medline: 27 8 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

Olfactory dysfunction (OD) is a highly frequent early non-motor symptom of Parkinson's disease (PD). An important step to potentially use OD for the development of early diagnostic tools of PD is to differentiate PD-related OD from other forms of non-parkinsonian OD (NPOD: postviral, sinunasal, post-traumatic, and idiopathic OD). Measuring non-olfactory chemosensory modalities, especially the trigeminal system, may allow to characterize a PD-specific olfactory profile. We here review the literature on PD-specific chemosensory alteration patterns compared with NPOD. Specifically, we focused on the impact of PD on the trigeminal system and particularly on the interaction between olfactory and trigeminal systems. As this interaction is seemingly affected in a disease-specific manner, we propose a model of interaction between both chemosensory systems that is distinct for PD-related OD and NPOD. These patterns of chemosensory impairment still need to be confirmed in prodromal PD; nevertheless, appropriate chemosensory tests may eventually help to develop diagnostic tools to identify individuals at risks for PD.

Identifiants

pubmed: 33835144
pii: 6218692
doi: 10.1093/chemse/bjab018
pmc: PMC8244988
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT 173514
Pays : Canada

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Chem Senses. 2005 Jan;30 Suppl 1:i205-6
pubmed: 15738116
J Parkinsons Dis. 2020;10(4):1587-1600
pubmed: 32597818
BMJ Open. 2012 Nov 06;2(6):
pubmed: 23135536
Int J Psychophysiol. 2017 Nov;121:18-21
pubmed: 28918916
J Neurol. 2018 Aug;265(8):1764-1771
pubmed: 29804147
Neuroscience. 2017 Nov 5;363:43-49
pubmed: 28739522
Mov Disord. 2009 May 15;24(7):1060-5
pubmed: 19353591
Int Arch Occup Environ Health. 2002 Jun;75(5):305-13
pubmed: 11981669
J Clin Neurosci. 2019 Oct;68:55-61
pubmed: 31383472
Curr Neurol Neurosci Rep. 2016 Oct;16(10):91
pubmed: 27568202
Clin Neurophysiol. 2007 Mar;118(3):690-5
pubmed: 17188566
Parkinsonism Relat Disord. 2015 Jul;21(7):698-703
pubmed: 25937615
J Neurol. 2019 Dec;266(12):2942-2951
pubmed: 31451911
Parkinsonism Relat Disord. 2018 Dec;57:68-71
pubmed: 30100363
Rhinology. 2016 Mar;54(1):27-31
pubmed: 26970101
Behav Neurosci. 2006 Feb;120(1):180-7
pubmed: 16492128
Chem Senses. 1996 Feb;21(1):75-9
pubmed: 8646495
Neurodegener Dis. 2018;18(2-3):143-149
pubmed: 29940577
Cereb Cortex. 2007 Oct;17(10):2268-75
pubmed: 17150985
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
Tohoku J Exp Med. 2015;237(2):111-6
pubmed: 26412299
J Comp Neurol. 2002 Mar 12;444(3):221-6
pubmed: 11840476
Electroencephalogr Clin Neurophysiol. 1988 Jul-Aug;71(4):241-50
pubmed: 2454788
Cereb Cortex. 2007 Feb;17(2):370-7
pubmed: 16525127
Laryngoscope. 2017 Feb;127(2):291-295
pubmed: 27556251
Mov Disord. 2017 Feb;32(2):219-226
pubmed: 28090684
Brain Res Rev. 2010 Mar;62(2):183-96
pubmed: 19913573
JAMA Neurol. 2017 Aug 1;74(8):933-940
pubmed: 28595287
PLoS One. 2012;7(3):e33221
pubmed: 22427997
Curr Allergy Asthma Rep. 2016 May;16(5):41
pubmed: 27131498
Electroencephalogr Clin Neurophysiol. 1992 Sep;83(3):201-10
pubmed: 1381671
Nat Commun. 2020 Jan 31;11(1):648
pubmed: 32005822
Brain Imaging Behav. 2017 Apr;11(2):430-443
pubmed: 26860909
J Neurol. 2019 Feb;266(2):339-345
pubmed: 30488238
Arch Neurol. 2011 Jul;68(7):932-7
pubmed: 21747034
J Neurol. 2020 Jan;267(1):138-143
pubmed: 31586261
Expert Rev Neurother. 2009 Dec;9(12):1773-9
pubmed: 19951136
Chem Senses. 2020 May 29;45(5):401-406
pubmed: 32249295
Neuroscience. 2007 Oct 12;149(1):223-31
pubmed: 17869005
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50
pubmed: 26662475
Brain Imaging Behav. 2019 Feb;13(1):210-219
pubmed: 29134611
Mov Disord. 2009 Apr 30;24(6):906-14
pubmed: 19205070
Front Integr Neurosci. 2010 Oct 28;4:125
pubmed: 21120143
Rhinology. 2012 Mar;50(1):13-21
pubmed: 22469600
Neuroscience. 2006 Oct 13;142(2):541-6
pubmed: 16844306
Chem Senses. 2013 Jan;38(1):3-17
pubmed: 22944611
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
PLoS One. 2018 Jan 5;13(1):e0190072
pubmed: 29304050
Rhinology. 2019 Oct 1;57(5):375-384
pubmed: 31576819
Eur J Neurosci. 2013 Feb;37(4):572-82
pubmed: 23205840
Expert Rev Neurother. 2021 Mar;21(3):365-379
pubmed: 33546569
Laryngoscope. 2004 Oct;114(10):1764-9
pubmed: 15454769
Front Neurol. 2018 Jun 06;9:419
pubmed: 29928255
Brain Res. 2019 Apr 1;1708:78-83
pubmed: 30537519
Hum Brain Mapp. 2015 May;36(5):1716-27
pubmed: 25640661
J Neurol Sci. 2010 Feb 15;289(1-2):119-22
pubmed: 19775703
Parkinsonism Relat Disord. 2010 Feb;16(2):79-84
pubmed: 19846332
Physiol Behav. 1975 Jun;14(6):855-9
pubmed: 1187843
Nat Rev Neurol. 2012 May 15;8(6):329-39
pubmed: 22584158
Neurology. 1988 Aug;38(8):1237-44
pubmed: 3399075
Parkinsonism Relat Disord. 2009 Aug;15(7):490-4
pubmed: 19138875
J Neurol. 2020 Feb;267(2):469-478
pubmed: 31676975
J Neurosci. 2009 Dec 9;29(49):15410-3
pubmed: 20007465
Nature. 1980 Mar 20;284(5753):255-7
pubmed: 7360255
Neurosci Lett. 1987 Jun 15;77(2):181-6
pubmed: 2439956
Chem Senses. 1997 Aug;22(4):457-65
pubmed: 9279468
Parkinsonism Relat Disord. 2017 Nov;44:85-90
pubmed: 28919173
Pain. 2008 Oct 15;139(2):376-388
pubmed: 18583050
Ann N Y Acad Sci. 2009 Jul;1170:190-5
pubmed: 19686136
Neurosci Lett. 2010 Jan 14;468(3):259-63
pubmed: 19900505
Eur J Neurosci. 2016 Nov 27;45(4):587-600
pubmed: 27891688
Hum Brain Mapp. 2014 Sep;35(9):4620-34
pubmed: 24639411
Otolaryngol Clin North Am. 2004 Dec;37(6):1159-66
pubmed: 15563908
Rhinology. 2008 Sep;46(3):170-4
pubmed: 18853866
Toxicol Lett. 2003 Apr 11;140-141:273-80
pubmed: 12676474
Dan Med J. 2018 May;65(5):
pubmed: 29726318
J Neural Transm (Vienna). 2019 Nov;126(11):1471-1478
pubmed: 31515655
Parkinsonism Relat Disord. 2018 Mar;48:17-27
pubmed: 29398491
Chem Senses. 2018 Sep 22;43(8):611-616
pubmed: 30052799
J Neural Transm (Vienna). 2013 Apr;120(4):571-6
pubmed: 23263541
ORL J Otorhinolaryngol Relat Spec. 2001 Mar-Apr;63(2):72-5
pubmed: 11244364
Int J Psychophysiol. 2007 Sep;65(3):177-81
pubmed: 17434636
J Neurosci. 2006 Feb 22;26(8):2269-77
pubmed: 16495454
Rhinol Suppl. 2017 Mar;54(26):1-30
pubmed: 29528615
QJM. 2010 Dec;103(12):941-52
pubmed: 20736182
Neurology. 1997 Nov;49(5):1424-31
pubmed: 9371933
J Formos Med Assoc. 2017 Aug;116(8):571-581
pubmed: 28532582
Parkinsons Dis. 2011;2011:450939
pubmed: 21687752
Brain Res. 2007 Mar 30;1139:235-44
pubmed: 17274965
J Neurol. 2017 Jun;264(6):1236-1246
pubmed: 28550478
Neuroimage Clin. 2020;28:102457
pubmed: 33068873
Brain. 2019 Mar 1;142(3):744-759
pubmed: 30789229
Int Rev Neurobiol. 2017;133:519-539
pubmed: 28802931

Auteurs

Cécilia Tremblay (C)

Department of Anatomy, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC, G9A 5H7, Canada.

Johannes Frasnelli (J)

Department of Anatomy, Université du Québec à Trois-Rivières, 3351 Boulevard des Forges, Trois-Rivières, QC, G9A 5H7, Canada.
Research Center, Sacré-Coeur Hospital of Montreal, 5400 Boulevard Gouin Ouest, Montréal, QC, H4J 1C5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH